Stanciu, G.D.; Ababei, D.-C.; Solcan, C.; Uritu, C.-M.; Craciun, V.-C.; Pricope, C.-V.; Szilagyi, A.; Tamba, B.-I.
Exploring Cannabinoids with Enhanced Binding Affinity for Targeting the Expanded Endocannabinoid System: A Promising Therapeutic Strategy for Alzheimer’s Disease Treatment. Pharmaceuticals 2024, 17, 530.
https://doi.org/10.3390/ph17040530
AMA Style
Stanciu GD, Ababei D-C, Solcan C, Uritu C-M, Craciun V-C, Pricope C-V, Szilagyi A, Tamba B-I.
Exploring Cannabinoids with Enhanced Binding Affinity for Targeting the Expanded Endocannabinoid System: A Promising Therapeutic Strategy for Alzheimer’s Disease Treatment. Pharmaceuticals. 2024; 17(4):530.
https://doi.org/10.3390/ph17040530
Chicago/Turabian Style
Stanciu, Gabriela Dumitrita, Daniela-Carmen Ababei, Carmen Solcan, Cristina-Mariana Uritu, Vlad-Constantin Craciun, Cosmin-Vasilica Pricope, Andrei Szilagyi, and Bogdan-Ionel Tamba.
2024. "Exploring Cannabinoids with Enhanced Binding Affinity for Targeting the Expanded Endocannabinoid System: A Promising Therapeutic Strategy for Alzheimer’s Disease Treatment" Pharmaceuticals 17, no. 4: 530.
https://doi.org/10.3390/ph17040530
APA Style
Stanciu, G. D., Ababei, D.-C., Solcan, C., Uritu, C.-M., Craciun, V.-C., Pricope, C.-V., Szilagyi, A., & Tamba, B.-I.
(2024). Exploring Cannabinoids with Enhanced Binding Affinity for Targeting the Expanded Endocannabinoid System: A Promising Therapeutic Strategy for Alzheimer’s Disease Treatment. Pharmaceuticals, 17(4), 530.
https://doi.org/10.3390/ph17040530
